Skip to main content
logo
Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
29.20
-1.48 (-4.82%)
Oct 2, 2026, 4:00 PM EDT - Market closed

Quince Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-92.48-83.98-56.83-31.39-51.66-89.95
Depreciation & Amortization
0.150.140.190.320.20.34
Loss (Gain) From Sale of Assets
----0.040.09-
Asset Writedown & Restructuring Costs
126.81-17.135.970.96-
Loss (Gain) From Sale of Investments
-0.49-1.01-2.35-2.02-0.110.88
Stock-Based Compensation
15.835.114.755.2216.6229.85
Other Operating Activities
-99.4525.485.691.67-0.310.2
Change in Accounts Payable
6.65-0.940.93-0.29-5.941.36
Change in Other Net Operating Assets
-3.9513.78-1.412.27-3.89-5.62
Operating Cash Flow
-46.92-41.43-31.9-18.29-44.04-62.93
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.08-0.35-0.26-0.16-0.13-0.18
Sale of Property, Plant & Equipment
---0.090.07-
Cash Acquisitions
8---2.1210.59-
Investment in Securities
18.3723.5822.17-2.577.4759.13
Other Investing Activities
----1--
Investing Cash Flow
26.2923.2321.91-5.761858.95

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
----0.01-0.05-
Net Debt Issued (Repaid)
-5.55---0.01-0.05-
Issuance of Common Stock
23.7517.910.230.150.766.81
Other Financing Activities
-0.06--5---
Financing Cash Flow
121.7917.91-4.780.140.716.81

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-2-0.110.230.080.180.06
Net Cash Flow
99.16-0.4-14.54-23.83-25.152.88

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-47-41.78-32.16-18.45-44.17-63.11
Free Cash Flow Growth
------
Free Cash Flow Per Share
-26.33-166.78-148.68-99.11-263.73-424.73
Levered Free Cash Flow
-25.75-10.61-21.13-1.94-24.18-30.54
Unlevered Free Cash Flow
-25.75-10.61-21.13-1.94-24.18-30.54

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.150.23----
Change in Working Capital
2.712.84-0.481.98-9.83-4.26
SEC Filings: 10-K · 10-Q